MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with C

Colesevelam

Colesevelam 625mg tablets

Use with caution

Stability notes for Colesevelam 625mg tablets

Moisture sensitive medicine. Store in airtight (sealed) MCA. Maximum 30 days in MCA.
Refer to individual SmPCs as manufacturer’s expiry after opening varies. No stability data in MCAs available. Original packaging may contain desiccant. Manufacturer recommends storing in original container.

Provenance

This recommendation is based on the products Cholestagel 625 mg film-coated tablets (Neon Healthcare Ltd) and Colesevelam hydrochloride 625 mg Film-Coated Tablets (Dr. Reddy's Laboratories (UK) Ltd).

Suppliers (7) of Colesevelam 625mg tablets
Cholestagel 625mg tablets (CST Pharma Ltd)
Cholestagel 625mg tablets (Neon Healthcare Ltd)
Colesevelam 625mg tablets (A A H Pharmaceuticals Ltd)
Colesevelam 625mg tablets (Accord-UK Ltd)
Colesevelam 625mg tablets (Alliance Healthcare (Distribution) Ltd)
Colesevelam 625mg tablets (Dr Reddy's Laboratories (UK) Ltd)
Colesevelam 625mg tablets (Zentiva Pharma UK Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.